UNIVERSITY OF NEVADA, LAS VEGAS

Global Alzheimer’s Platform Foundation (GAP) and University of Nevada, Las Vegas (UNLV) announce MOU to accelerate neurodegenerative disease research, establishing a state-of-the-art imaging and technology program for CNS research, aiming to enhance clinical trials and brain health programs in Southern Nevada.

GAP and UNLV announce MOU to accelerate neurodegenerative disease research, focusing on CNS biomarker and diagnostic solutions, and enhancing clinical trial access for Southern Nevadans.

The Alzheimer's Drug Discovery Foundation (ADDF) announced a new investment to develop a Biomarker Observatory, led by Dr. Jeffrey Cummings and Co-Principal Investigator Feixiong Cheng, to provide a comprehensive overview of Alzheimer's biomarkers, accelerating drug development. The Observatory will complement Cummings' annual clinical trial report and serve as a key resource for researchers, bridging gaps in Alzheimer's research and advancing precision medicine.